The Latest Cardiac and Vascular News
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, announced today a strategic partnership with BLOXR Solutions, a leading provider of radiation protection products designed to reduce exposure for clinicians and patients. The three-year distribution agreement grants Corindus the non-exclusive rights to distribute […]
By Ken Dropkiewski The bioresorbable stent was approved for use by the FDA in July of 2016. The Absorb GT1 Bioresorbable Vascular Scaffold System, manufactured by Abbott, was all set to solve a litany of the problems inherent with conventional cardiac and vascular stents. Conventional stents, made of flexible metal […]
ANN ARBOR, Mich., April 6, 2017 /PRNewswire/ — Terumo Cardiovascular (CV) Group today announced that Robert (Rob) DeRyke has been appointed President and CEO of Terumo CV Group, effective April 1, 2017, following the retirement of long-time President and CEO Mark Sutter. In this position, DeRyke will lead Terumo’s global business […]
PCRonline/News/Industry Press Releases – 04 April, 2017 MASTER-DAPT kicks-off with the enrolment of its first patient by Treant Zorggroep, Scheper Hospital Emmen, The Netherlands – Dr Gillian Jessurun from Treant Zorggroep, Scheper Hospital has enrolled the first patient in the investigator initiated MASTER DAPT (MAnagement of patients post bioresorbable polymer STEnt […]
PCRonline/News/Industry Press Releases – 15 May, 2017 DUBLIN, Ohio. Cordis, Cardinal Health‘s interventional vascular business, announced today the commercial launch of three new products that further enhance its interventional cardiology product portfolio in Europe, the Middle East, and Africa (EMEA). The addition of the Cordis RAILWAY Sheathless Access System as well […]
NEWS PROVIDED BY – Occlutech – 05 Apr, 2017, 07:00 ET SCHAFFHAUSEN, Switzerland, April 5, 2017 /PRNewswire/ — Occlutech, a leading innovator of implants to treat structural heart disease, today announced that it has obtained European CE Mark approval for its Perimembranous Ventricular Septal Defect (PmVSD) Occluder. The device is a […]
SAN DIEGO, April 03, 2017 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce it has received CE Mark approval for its Fantom drug-eluting bioresorbable coronary scaffold, which offers multiple and substantial performance advantages over first-generation scaffolds on the market today. Fantom is REVA’s […]
MALVERN, Pennsylvania, April 3, 2017 /PRNewswire/ — Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced the publication of the MANTA CE marking study results in JACC Interventions titled: “Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access” (http://dx.doi.org/10.1016/j.jcin.2016.12.277). This first, […]
Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts – Governor Baker joins heart recovery leader for grand opening of new manufacturing and training space that represents major investment in Massachusetts DANVERS, Mass., March 30, 2017 (GLOBE NEWSWIRE) — Massachusetts Governor Charlie Baker today joined Abiomed – a leading […]
Cardiovascular Systems, Inc. Receives Approval for the Diamondback 360® Coronary Orbital Atherectomy System (OAS) Micro Crown in the United States OAS Micro Crown Approved to Treat Severely Calcified Coronary Lesions Only Atherectomy Device Designed to Both Pilot Tight Lesions and Treat Up to 4mm Vessels with a Single Device ST. […]
